Medical science is evolving at a historic pace. Breakthrough treatments that were once deemed impossible are now becoming a reality, offering families renewed hope in the face of devastating diagnoses. However, these medical advancements highlight a critical truth about modern healthcare: innovation comes with a significant price tag, and public health systems cannot always cover every cost immediately.
Just look at the Lecanemab (brand name Leqembi) - a groundbreaking disease-modifying therapy for early-stage Alzheimer’s disease - and its recent journey through Canada's approval process. This drug's journey is important because it provides one simple example of why personal financial protection, specifically Critical Illness Insurance, is no longer optional in Canada.
In February 2026, Canada's Drug Agency - a pan-Canadian health organization, created and funded by Canada’s federal, provincial, and territorial governments - issued an initial preliminary draft recommending against public drug plan coverage of Lecanemab. The reasons were not simple but they included safety concerns like brain swelling or bleeding as well as the high annual costs. Costs which would likely be about $26,500 USD per year.
Now, this was not the final step in the process because the decision was reviewed. Recognizing the drug's clinical value in slowing cognitive decline, the subsequent review requested by the manufacturer (Eisai) led the expert committee to reverse its stance. However, even though the drug might be paid for by public plans - provincial, federal and territorial - qualifying for payment will be restricted by specific criteria. This means that integration within the general system will not be extensive, it will be a complex process to navigate and the use of the drug will be terribly limited.
As a result, if you were unlucky to get an early-stage Alzheimer’s diagnosis, and didn’t meet the strict criteria set out by Health Canada, you would find that your treatment choices would be limited. Even worse, if your physician and you decided that this was suitable treatment, you would have to pay out of pocket. To remind you, right now, the manufacturer’s list price for this intravenous (IV) drug is $26,500 USD per year. Coupled with Foreign Exchange Rates, this could cost as much as $32,000 and $40,000 CAD, translating to roughly $3,000 to $4,000 CAD ($2,200 to $3,300 USD) every single month depending on patient weight, dosing methods (bi-weekly IV infusions vs. weekly subcutaneous options), and interprovincial pricing. For most Canadians such a cost would break the bank.
However, there is more to consider because the drug's price tag is only part of the equation. Alzheimer’s patients require expensive diagnostic and genetic testing beforehand, regular PET scans, clinical administration fees for IV infusions, and ongoing serial MRI scans to monitor for potential side effects. Many of these costs are out-of-pocket expenses that fall directly on you and your family.
Even as public health agencies adapt to novel therapies, relying solely on government healthcare can leave families facing thousands of dollars per month in uncovered drug costs, diagnostic scans, and specialized care.
So in many cases, the solution is a simple one: protecting your health and wealth. While you cannot always predict a health crisis, you can control your financial readiness. Critical Illness Insurance in Canada is designed specifically to bridge the gap between provincial health coverage and the true, multi-faceted cost of recovery.
How does this work? Upon diagnosis of a covered severe health condition, a critical illness policy pays a tax-free, one-time lump sum directly to you—typically ranging from $25,000 up to $2 million. Unlike traditional benefits tied to specific medical receipts, this payout is yours to control with complete flexibility.
The true strength of a critical illness lump-sum payout lies in its versatility. When facing a critical illness, financial stress should be the last thing on your mind. You can use the funds however you see fit:
- Pay for Specialized Out-of-Pocket Treatments: Cover cutting-edge drugs like Leqembi, off-label medications, out-of-country specialist consultations, or essential private diagnostic imaging without depleting your lifetime savings.
- Replace Lost Income: Give yourself and your family members the freedom to take time off work for caregiving and recovery without sacrificing monthly income.
- Manage Household Bills: Keep up with mortgage payments, everyday living expenses, debt obligations, or childcare needs.
- Adapt Your Living Environment: Fund home modifications or arrange private in-home healthcare assistance to ensure safety and comfort.
Medical science is delivering incredible breakthroughs every year, giving patients more quality time with their loved ones. However, gaining timely access to these life-changing therapies frequently requires private financial resources.
By securing an enhanced Critical Illness Insurance policy today, you ensure that if a major diagnosis ever happens, your focus can remain entirely where it belongs: on your health, your recovery, and your family.
Comments
Post a Comment